The Development International Birth Date (DIBD) is the date on which the first authorization for conducting an interventional clinical trial in any country is granted. This date marks the inception of the global development process for a specific clinical trial, which may involve testing a new medical intervention or pharmaceutical product. It is a crucial milestone in the research and development of such interventions.
Confounding by Indication
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management